| 37202560 | An integrated tumor, immune and microbiome atlas of colon cancer. | Nat Med | 2023 |
| 37291737 | V<sub>4</sub> C<sub>3</sub> MXene Immune Profiling and Modulation of T Cell-Dendritic Cell Function and Interaction. | Small Methods | 2023 |
| 37448622 | Organizing training workshops on gene literature retrieval, profiling, and visualization for early career researchers. | F1000Res | 2023 |
| 34796889 | Graphene oxide activates B cells with upregulation of granzyme B expression: evidence at the single-cell level for its immune-modulatory properties and anticancer activity. | Nanoscale | 2022 |
| 35690832 | The immune landscape of solid pediatric tumors. | J Exp Clin Cancer Res | 2022 |
| 36595917 | Analytic pipelines to assess the relationship between immune response and germline genetics in human tumors. | STAR Protoc | 2022 |
| 36180904 | Immune-related 3-lncRNA signature with prognostic connotation in a multi-cancer setting. | J Transl Med | 2022 |
| 36207284 | Immune Profiling and Multiplexed Label-Free Detection of 2D MXenes by Mass Cytometry and High-Dimensional Imaging. | Adv Mater | 2022 |
| 36367935 | High-temporal resolution profiling reveals distinct immune trajectories following the first and second doses of COVID-19 mRNA vaccines. | Sci Adv | 2022 |
| 36293565 | Correlation of Immunological and Histopathological Features with Gene Expression-Based Classifiers in Colon Cancer Patients. | Int J Mol Sci | 2022 |
| 36215697 | Loss of ribonuclease DIS3 hampers genome integrity in myeloma by disrupting DNA:RNA hybrid metabolism. | EMBO J | 2022 |
| 33926791 | miRNAs as novel immunoregulators in cancer. | Semin Cell Dev Biol | 2022 |
| 35017155 | Immunologic constant of rejection signature is prognostic in soft-tissue sarcoma and refines the CINSARC signature. | J Immunother Cancer | 2022 |
| 35150601 | Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort study. | Lancet Oncol | 2022 |
| 35303879 | Liquid biopsy: a step closer to transform diagnosis, prognosis and future of cancer treatments. | Mol Cancer | 2022 |
| 35174610 | Transcriptomic profile investigations highlight a putative role for NUDT16 in sepsis. | J Cell Mol Med | 2022 |
| 34789537 | Fasting-Mimicking Diet Is Safe and Reshapes Metabolism and Antitumor Immunity in Patients with Cancer. | Cancer Discov | 2022 |
| 33390169 | Cytokine-chemokine network driven metastasis in esophageal cancer; promising avenue for targeted therapy. | Mol Cancer | 2021 |
| 33602280 | Emerging dynamics pathways of response and resistance to PD-1 and CTLA-4 blockade: tackling uncertainty by confronting complexity. | J Exp Clin Cancer Res | 2021 |
| 33624743 | BloodGen3Module: blood transcriptional module repertoire analysis and visualization using R. | Bioinformatics | 2021 |
| 33753982 | 2D MXenes with antiviral and immunomodulatory properties: A pilot study against SARS-CoV-2. | Nano Today | 2021 |
| 33637674 | Correction: Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy. | Signal Transduct Target Ther | 2021 |
| 33614648 | Insights Into the Role of CircRNAs: Biogenesis, Characterization, Functional, and Clinical Impact in Human Malignancies. | Front Cell Dev Biol | 2021 |
| 33558495 | Ancestry-associated transcriptomic profiles of breast cancer in patients of African, Arab, and European ancestry. | NPJ Breast Cancer | 2021 |
| 34956864 | Bulk and Single-Cell Profiling of Breast Tumors Identifies TREM-1 as a Dominant Immune Suppressive Marker Associated With Poor Outcomes. | Front Oncol | 2021 |
| 34303699 | Myeloid Cells Are Enriched in Tonsillar Crypts, Providing Insight into the Viral Tropism of Human Papillomavirus. | Am J Pathol | 2021 |
| 34185403 | Integrated transcriptional-phenotypic analysis captures systemic immunomodulation following antiangiogenic therapy in renal cell carcinoma patients. | Clin Transl Med | 2021 |
| 33979427 | Network-based identification of key master regulators associated with an immune-silent cancer phenotype. | Brief Bioinform | 2021 |
| 34282143 | Development of a fixed module repertoire for the analysis and interpretation of blood transcriptome data. | Nat Commun | 2021 |
| 33436555 | Tumor microenvironment: an evil nexus promoting aggressive head and neck squamous cell carcinoma and avenue for targeted therapy. | Signal Transduct Target Ther | 2021 |
| 33408218 | Prospective validation study of prognostic biomarkers to predict adverse outcomes in patients with COVID-19: a study protocol. | BMJ Open | 2021 |
| 33139798 | A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival. | Br J Cancer | 2021 |
| 33277603 | Correction: A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival. | Br J Cancer | 2021 |
| 31502155 | Functional Genome Profiling to Understand Cancer Immune Responsiveness. | Methods Mol Biol | 2020 |
| 35121932 | Flt3 ligand augments immune responses to anti-DEC-205-NY-ESO-1 vaccine through expansion of dendritic cell subsets. | Nat Cancer | 2020 |
| 33377660 | Definition of erythroid cell-positive blood transcriptome phenotypes associated with severe respiratory syncytial virus infection. | Clin Transl Med | 2020 |
| 33142138 | Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome. | Mol Immunol | 2020 |
| 33329570 | A Neutrophil-Driven Inflammatory Signature Characterizes the Blood Transcriptome Fingerprint of Psoriasis. | Front Immunol | 2020 |
| 33155039 | A map of tumor-host interactions in glioma at single-cell resolution. | Gigascience | 2020 |
| 32711099 | Sterol synthesis pathway inhibition as a target for cancer treatment. | Cancer Lett | 2020 |
| 32682335 | Annexin A3 in sepsis: novel perspectives from an exploration of public transcriptome data. | Immunology | 2020 |
| 32630545 | HLA-G: A New Immune Checkpoint in Cancer? | Int J Mol Sci | 2020 |
| 32736569 | A modular framework for the development of targeted Covid-19 blood transcript profiling panels. | J Transl Med | 2020 |
| 32931741 | A Multi-layer Molecular Fresco of the Immune Diversity across Hematologic Malignancies. | Cancer Cell | 2020 |
| 32393282 | Differential responsiveness to BRAF inhibitors of melanoma cell lines BRAF V600E-mutated. | J Transl Med | 2020 |
| 32338440 | Toward High-Dimensional Single-Cell Analysis of Graphene Oxide Biological Impact: Tracking on Immune Cells by Single-Cell Mass Cytometry. | Small | 2020 |
| 32215869 | The Biology of Immune-Active Cancers and Their Regulatory Mechanisms. | Cancer Treat Res | 2020 |
| 32519842 | Toward Nanotechnology-Enabled Approaches against the COVID-19 Pandemic. | ACS Nano | 2020 |
| 32373222 | Graphene and other 2D materials: a multidisciplinary analysis to uncover the hidden potential as cancer theranostics. | Theranostics | 2020 |
| 30953523 | Monoallelic expression in melanoma. | J Transl Med | 2019 |